VHI VALHI INC /DE/
Industrial Inorganic Chemicals · NYSE · SEC CIK 59255 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.0%
TTM net income YoY-92.9%
TTM EPS YoY-93.8%
Revenue 3-yr CAGR6.3%
Net income 3-yr CAGR—
Margins
Gross margin17.8%
Operating margin6.1%
Net margin0.1%
FCF margin5.3%
EBITDA margin9.1%
Returns
ROE0.1%
ROA0.0%
ROIC (approx.)6.8%
Asset turnover0.85x
Leverage & solvency
Liabilities / assets44.6%
Debt / equity0.52x
Current ratio3.29x
Interest coverage2.35x
Cash quality & payout
Operating cash flow / net income132.54x
Accruals ratio-6.5%
Payout ratio700.0%
Capex / revenue2.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.08B | $2.10B | $1.92B | $2.22B | $2.30B |
| Cost of revenue | $1.78B | $1.68B | $1.68B | $1.73B | $1.72B |
| Gross profit | $295.40M | $424.50M | $245.20M | $490.40M | $580.20M |
| R&D expense | $17.00M | $14.00M | $18.00M | $16.00M | $17.00M |
| SG&A expense | $312.30M | $256.20M | $277.40M | $304.00M | $311.90M |
| Operating income | $63.30M | $210.70M | $34.20M | $239.40M | $318.60M |
| Interest expense | $57.10M | $49.90M | $28.30M | $27.90M | $32.50M |
| Pretax income | -$43.00M | $244.20M | -$19.50M | $169.90M | $257.80M |
| Income tax | $11.90M | $82.90M | -$24.60M | $36.80M | $60.10M |
| Net income | -$57.60M | $108.00M | -$9.90M | $87.20M | $127.20M |
| EBITDA | $129.70M | $277.40M | $88.30M | $297.90M | $377.90M |
| EPS (basic) | -2.02 | 3.79 | -0.35 | 3.06 | 4.46 |
| EPS (diluted) | -2.02 | 3.79 | -0.35 | 3.06 | 4.46 |
| Dividends declared per share | 0.32 | 0.32 | 0.32 | 0.32 | 0.32 |
| Weighted avg. shares (diluted) | 28 | 28 | 28 | 28 | 28.50M |
| Balance sheet | |||||
| Cash & equivalents | $214.00M | $348.30M | $407.00M | $478.50M | $698.40M |
| Short-term investments | $2.90M | $1.90M | $56.10M | $75.10M | $2.60M |
| Inventory | $659.80M | $685.80M | $596.10M | $640.80M | $458.70M |
| Current assets | $1.26B | $1.45B | $1.48B | $1.59B | $1.67B |
| PP&E, net | $751.60M | $723.40M | $517.30M | $523.80M | $563.60M |
| Goodwill | $382.30M | $382.30M | $379.70M | $379.70M | $379.70M |
| Total assets | $2.63B | $2.80B | $2.74B | $2.84B | $3.01B |
| Current liabilities | $449.30M | $643.80M | $507.10M | $492.80M | $463.50M |
| Short-term debt | $800,000 | $79.00M | $700,000 | $1.80M | $3.10M |
| Long-term debt | $590.90M | $484.40M | $545.80M | $557.70M | $649.90M |
| Total debt | $591.70M | $563.40M | $546.50M | $559.50M | $653.00M |
| Total liabilities | $1.27B | $1.42B | $1.46B | $1.52B | $1.83B |
| Shareholders' equity | $1.02B | $1.04B | $950.50M | $958.60M | $829.50M |
| Net debt | $377.70M | $215.10M | $139.50M | $81.00M | -$45.40M |
| Shares outstanding | 29.60M | 29.60M | 29.60M | 29.60M | 29.60M |
| Cash flow statement | |||||
| Operating cash flow | -$35.50M | $44.00M | $3.90M | $34.90M | $459.70M |
| Capital expenditure | $46.60M | $30.90M | $48.50M | $67.60M | $64.10M |
| Free cash flow | -$82.10M | $13.10M | -$44.60M | -$32.70M | $395.60M |
| Investing cash flow | -$47.80M | -$125.00M | -$29.00M | -$146.70M | -$37.40M |
| Financing cash flow | -$71.10M | -$2.30M | -$75.90M | -$114.00M | -$189.10M |
| Depreciation & amortization | $66.40M | $66.70M | $54.10M | $58.50M | $59.30M |
| Dividends paid | $9.10M | $9.10M | $9.10M | $9.00M | $9.00M |
| Share buybacks | — | — | $2.90M | $4.00M | $1.50M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.